Skip to main content
. 2020 Dec 5;19:204. doi: 10.1186/s12933-020-01182-6

Fig. 2.

Fig. 2

Percentage of progressive diabetic metabolic disorder (DMD), stable or improved glucose metabolism (GM) between baseline and 1 year follow up in the multifactorial intervention group of the ASPIS trial and in controls. Both, OGTT and HbA1c were used for diagnosis, patients were classified to PD or T2DM if either the OGTT or HbA1c criteria were fulfilled. Progressive DMD was defined as progression from normal GM to PD or T2DM or from PD to T2DM, improved GM as change of GM in the opposite direction